The effect of Terazosin and Tolterodine in the treatment of double J stent-related urinary symptoms
Phase 3
- Conditions
- lower urinary tract symptoms, ureteral stone.Urinary calculus, unspecifiedN20.9
- Registration Number
- IRCT20160924029935N2
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
patients with ureteral stones undergoing unilateral transurethral lithotripsy
Exclusion Criteria
History of major urinary surgery
Benign prostate hyperplasia under medical therapy
Overactive bladder
Drug sensitivity
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method reteral stent urinary symptoms. Timepoint: 2 weeks after intervention. Method of measurement: Ureteral Stent Symptoms Questionnaire.
- Secondary Outcome Measures
Name Time Method